86 results
Page 3 of 5
8-K
EX-99.1
b33wlfymgluted2cza
16 Mar 20
Regulation FD Disclosure
7:27am
8-K
EX-99.1
uk4c4n loz7fyf
13 Feb 20
Blueprint Medicines Reports Fourth Quarter and Full Year 2019 Financial Results
7:21am
424B5
boa 3rqpt
23 Jan 20
Prospectus supplement for primary offering
4:24pm
424B5
4kheuw4unhkz4ewcog
21 Jan 20
Prospectus supplement for primary offering
4:44pm
8-K
EX-99.1
qkjtt2puqnfkyoa
9 Dec 19
Blueprint Medicines Announces Initial Data from Phase 2 PIONEER Trial of Avapritinib
7:31am
8-K
EX-99.3
7b6j4rd
9 Dec 19
Blueprint Medicines Announces Initial Data from Phase 2 PIONEER Trial of Avapritinib
7:31am
8-K
9he4w6wa r8mf
9 Dec 19
Blueprint Medicines Announces Initial Data from Phase 2 PIONEER Trial of Avapritinib
7:31am
8-K
EX-99.1
idmxij e648et
5 Nov 19
Results of Operations and Financial Condition
7:16am
8-K
EX-99.1
1j14kevs
16 Oct 19
Entry into a Material Definitive Agreement
6:51am
8-K
EX-99.1
svx9ih5jht mdbdmnc
1 Aug 19
Blueprint Medicines Reports Second Quarter 2019 Financial Results
7:31am
8-K
ehvws
4 Jun 19
Regulation FD Disclosure
7:30am
8-K
EX-99.3
6kygy9fnhk8hdj8fuvl
3 Jun 19
Regulation FD Disclosure
9:11am
8-K
sp87zqvnh2 9gmjs
3 Jun 19
Regulation FD Disclosure
9:11am
8-K
EX-99.4
njgd3mymb
3 Jun 19
Regulation FD Disclosure
9:11am
8-K
EX-99.1
xw3494 hwrkax
3 Jun 19
Regulation FD Disclosure
9:11am
8-K
EX-99.2
1wti7u82gwk74 vws1e
3 Jun 19
Regulation FD Disclosure
9:11am